Exscientia 17. Dez. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Clinical Data Readout - Quiver Quantitative
Exscientia 30. Okt. 2025 BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Exscientia 13. Okt. 2025 Exscientia Wins Dismissal of Investor Suit Over CEO Misconduct - Bloomberg Law News
Exscientia 2. Okt. 2024 Exscientia outline robot and AI use in drug discovery workflow - Clinical Trials Arena